Weitz & Luxenberg | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

9 results for “Weitz & Luxenberg”

Trials

Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg

25 participants · First posted Sep 19, 2005

Drugs

Radix Sanguisorbae Sapogenin (Sichuan Inlu Weite Pharmaceutical Technology)

GABAA receptor agonists(Universitätsmedizin der Johannes Gutenberg-Universität Mainz)

1 methylpseudouridine-modified messenger RNA(The Johannes Gutenberg University of Mainz)

Organizations

Johannes Gutenberg-Universität Mainz

Germany

News

GLP-1 Drugs Face Mounting NAION Lawsuits as Regulators Split on Vision-Loss Warnings

Abelacimab Shows Low Bleeding Rates in Phase 2 Periprocedural Trial, May Simplify Anticoagulation Management

NCT/UCC Dresden Launches Phase 2 Trial of Personalized mRNA Vaccine for Pancreatic Cancer